{"mainPropery":{"diseaseId":3588,"diseaseName":"Mevalonic aciduria","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/3588/mevalonic-aciduria","synonyms":["Complete mevalonate kinase deficiency","Mevalonicaciduria","MVA"],"synonyms-with-source":[{"name":"Complete mevalonate kinase deficiency","source":"ORPHANET"},{"name":"Mevalonicaciduria"},{"name":"MVA","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"OMIM","identifierId":"610377"},{"identifierType":"ORPHANET","identifierId":"29"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":15,"diseaseTypeName":"Musculoskeletal Diseases","source":"Orphanet"},{"diseaseTypeId":33,"diseaseTypeName":"RDCRN"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":3600,"resourceName":"FMF & AID Global Association","abbreviation":"","address1":"Schüracherstrasse 25a","address2":"8306 Brüttisellen","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Switzerland","phone":"+41 76 415 4010","tty":"","tollFree":"","fax":"","email":"info@fmfandaid.org ","url":"https://www.fmfandaid.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/610377' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=omim_Detailed&db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=610377' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Mevalonic aciduria. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Mevalonic+aciduria%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Mevalonic aciduria. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/mevalonate-kinase-deficiency' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Mevalonic aciduria. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":879,"resourceId":1585,"resourceName":"RDCRN - Steroid and Isoprenoid Research Consortium (STAIR)","descriptionText":"The <a href='https://www.rarediseasesnetwork.org/cms/stair/' target='_blank'>Sterol and Isoprenoid Diseases Consortium (STAIR)</a> is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition through research. The Steroid and Isoprenoid Research Consortium (STAIR) has a registry for patients who wish to be contacted about clinical research opportunities. <br /><br />For more information on the registry see: <a href='https://www.rarediseasesnetwork.org/cms/stair/Get-Involved/ContactRegistry' target='_blank'>https://www.rarediseasesnetwork.org/cms/stair/Get-Involved/ContactRegistry</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1959626' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=29' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:610377' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":5942,"questionText":"What is mevalonic aciduria?","answerText":"<strong>Mevalonic aciduria</strong>&nbsp;is the severe&nbsp;form of&nbsp;mevalonate kinase deficiency,&nbsp;a condition characterized by recurrent episodes of fever that&nbsp;typically begin during infancy.[4932]&nbsp;During these fever episodes, people with&nbsp;mevalonic aciduria may have an enlarged liver and spleen (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/17215.htm\" target=_blank>hepatosplenomegaly</a>), <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003097.htm\" target=_blank>lymphadenopathy</a>, abdominal pain, diarrhea, joint pain (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003261.htm\" target=_blank>arthralgia</a>), and skin rashes. Additional ongoing&nbsp;issues include&nbsp;developmental delay, progressive <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003198.htm\" target=_blank>ataxia</a>, progressive problems with vision, an unusually small, elongated head, and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=_blank>failure to thrive</a>.[4932][4933]&nbsp;Mevalonic aciduria is caused by deficiency of mevalonate kinase, the first committed enzyme of cholesterol biosynthesis.[4933] This deficiency occurs as a result of inherited mutations in the&nbsp;<span class=geneSymbol><em><a href=\"http://ghr.nlm.nih.gov/gene/MVK\" target=_blank>MVK</a></em></span> gene.[4932][4933] This condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> pattern.[4932] Treatment is challenging and remains mainly supportive.[4933] \r\n<p>The less severe type of mevalonate kinase deficiency is called <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/2788/Hyperimmunoglobulinemia_D_and_periodic_fever_syndrome.aspx\" target=_blank>hyperimmunoglobulinemia D syndrome</a> (HIDS).[4932]&nbsp;</p>","dateModified":"2012-02-06T22:52:00"},"basicQuestions":[{"questionId":5943,"questionText":"How might mevalonic aciduria be treated?","answerText":"Treatment of mevalonic aciduria remains a challenge.[4934] There is&nbsp;no standard treatment that is effective in all patients, so it remains mainly supportive.[4933] Treatment with <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a692030.html\" target=_blank>simvastatin</a> (an inhibitor of hydroxymethylglutaryl coenzyme A reductase, the enzyme that catalyzes the formation of mevalonic acid), which has been used with guarded success in patients with&nbsp;HIDS,&nbsp;worsened the clinical status of two patients with mevalonic aciduria.[4935] <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a602001.html\" target=_blank>Anakinra</a>, another medication used with&nbsp;some degree of success in HIDS patients, induced partial remission in at least one patient with mevalonic aciduria, but not all patients respond to so favorably.[4934]&nbsp; \r\n<p>Reports of successful treatment of mevalonic aciduria through <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003009.htm\" target=_blank>allogenic bone marrow transplantation</a> have also surfaced. At this point, this therapy&nbsp;is investigational and potentially applicable to patients with mevalonic aciduria whose condition is resistant to therapy with anti-inflammatory drugs (e.g., inhibitors of TNF-alpha and interleukin-1 beta).[4935][4936] </p>\r\n<p>The following articles provide additional details regarding treatment of mevalonic aciduria. <br><br>Nevyjel M, Pontillo A, Calligaris L, Tommasini A, D'Osualdo A, Waterham HR, Granzotto M, Crovella S, Barbi E, Ventura A. <a href=\"http://pediatrics.aappublications.org/content/119/2/e523.full.pdf+html\" target=_blank>Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency</a>. Pediatrics. 2007 Feb;119(2):e523-7. </p>\r\n<p class=desc>Neven B, Valayannopoulos V, Quartier P, Blanche S, Prieur AM, Debré M, Rolland MO, Rabier D, Cuisset L, Cavazzana-Calvo M, de Lonlay P, Fischer A.&nbsp;<font color=#000000><a href=\"http://www.nejm.org/doi/pdf/10.1056/NEJMoa070715\" target=_blank>Allogeneic bone marrow transplantation in mevalonic aciduria</a>.</font><span class=jrnl title=\"The New England journal of medicine\">&nbsp;N Engl J Med</span>. 2007 Jun 28;356(26):2700-3.</p>\r\n<p class=desc>Arkwright PD, Abinun M, Cant AJ.&nbsp;<font color=#000000><a href=\"http://www.nejm.org/doi/full/10.1056/NEJMc072018\" target=_blank>Mevalonic aciduria cured by bone marrow transplantation</a>.</font><span class=jrnl title=\"The New England journal of medicine\">&nbsp;N Engl J Med</span>. 2007 Sep 27;357(13):1350.</p>","dateModified":"2012-02-02T14:43:00","resourceClassificationName":"Treatment","references":[{"referenceId":4933,"authors":"Haas D, Hoffmann GF","articleTitle":"Mevalonic aciduria","bookWebsiteJournalTitle":"Orphanet","date":"April 2006","url":"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=403&Disease_Disease_Search_diseaseGroup=Mevalonic-aciduria&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Mevalonic-aciduria&title=Mevalonic-aciduria&searc","dateAccessed":"2012-02-02T00:00:00"},{"referenceId":4934,"authors":"Bodar EJ, Kuijk LM, Drenth JP, van der Meer JW, Simon A, Frenkel J","articleTitle":"On-demand anakinra treatment is effective in mevalonate kinase deficiency","bookWebsiteJournalTitle":"Ann Rheum Dis","date":"Dec 2011","url":"http://www.ncbi.nlm.nih.gov/pubmed/21859689","dateAccessed":"2012-02-02T00:00:00"},{"referenceId":4935,"authors":"Neven B, Valayannopoulos V, Quartier P, Blanche S, Prieur AM, Debré M, Rolland MO, Rabier D, Cuisset L, Cavazzana-Calvo M, de Lonlay P, Fischer A","articleTitle":"Allogeneic Bone Marrow Transplantation in Mevalonic Aciduria","bookWebsiteJournalTitle":"New England Journal of Medicine","date":"2007","url":"http://www.nejm.org/doi/full/10.1056/NEJMoa070715#t=articleTop","dateAccessed":"2012-02-02T00:00:00"},{"referenceId":4936,"authors":"Arkwright PD, Abinun M, Cant AJ","articleTitle":"Mevalonic Aciduria Cured by Bone Marrow Transplantation","bookWebsiteJournalTitle":"New England Journal of Medicine","date":"2007","url":"http://www.nejm.org/doi/full/10.1056/NEJMc072018","dateAccessed":"2012-02-02T00:00:00"}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":33792,"abbreviatedInquiry":"Is enzyme therapy (utilizing a&nbsp;synthetic form of mevalonate kinase) available for mevalonic aciduria?","caseQuestions":[{"questionId":5943,"questionText":"How might mevalonic aciduria be treated?","answerText":"Treatment of mevalonic aciduria remains a challenge.[4934] There is&nbsp;no standard treatment that is effective in all patients, so it remains mainly supportive.[4933] Treatment with <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a692030.html\" target=_blank>simvastatin</a> (an inhibitor of hydroxymethylglutaryl coenzyme A reductase, the enzyme that catalyzes the formation of mevalonic acid), which has been used with guarded success in patients with&nbsp;HIDS,&nbsp;worsened the clinical status of two patients with mevalonic aciduria.[4935] <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a602001.html\" target=_blank>Anakinra</a>, another medication used with&nbsp;some degree of success in HIDS patients, induced partial remission in at least one patient with mevalonic aciduria, but not all patients respond to so favorably.[4934]&nbsp; \r\n<p>Reports of successful treatment of mevalonic aciduria through <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003009.htm\" target=_blank>allogenic bone marrow transplantation</a> have also surfaced. At this point, this therapy&nbsp;is investigational and potentially applicable to patients with mevalonic aciduria whose condition is resistant to therapy with anti-inflammatory drugs (e.g., inhibitors of TNF-alpha and interleukin-1 beta).[4935][4936] </p>\r\n<p>The following articles provide additional details regarding treatment of mevalonic aciduria. <br><br>Nevyjel M, Pontillo A, Calligaris L, Tommasini A, D'Osualdo A, Waterham HR, Granzotto M, Crovella S, Barbi E, Ventura A. <a href=\"http://pediatrics.aappublications.org/content/119/2/e523.full.pdf+html\" target=_blank>Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency</a>. Pediatrics. 2007 Feb;119(2):e523-7. </p>\r\n<p class=desc>Neven B, Valayannopoulos V, Quartier P, Blanche S, Prieur AM, Debré M, Rolland MO, Rabier D, Cuisset L, Cavazzana-Calvo M, de Lonlay P, Fischer A.&nbsp;<font color=#000000><a href=\"http://www.nejm.org/doi/pdf/10.1056/NEJMoa070715\" target=_blank>Allogeneic bone marrow transplantation in mevalonic aciduria</a>.</font><span class=jrnl title=\"The New England journal of medicine\">&nbsp;N Engl J Med</span>. 2007 Jun 28;356(26):2700-3.</p>\r\n<p class=desc>Arkwright PD, Abinun M, Cant AJ.&nbsp;<font color=#000000><a href=\"http://www.nejm.org/doi/full/10.1056/NEJMc072018\" target=_blank>Mevalonic aciduria cured by bone marrow transplantation</a>.</font><span class=jrnl title=\"The New England journal of medicine\">&nbsp;N Engl J Med</span>. 2007 Sep 27;357(13):1350.</p>","dateModified":"2012-02-02T14:43:00","resourceClassificationName":"Treatment","references":[{"referenceId":4933,"authors":"Haas D, Hoffmann GF","articleTitle":"Mevalonic aciduria","bookWebsiteJournalTitle":"Orphanet","date":"April 2006","url":"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=403&Disease_Disease_Search_diseaseGroup=Mevalonic-aciduria&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Mevalonic-aciduria&title=Mevalonic-aciduria&searc","dateAccessed":"2012-02-02T00:00:00"},{"referenceId":4934,"authors":"Bodar EJ, Kuijk LM, Drenth JP, van der Meer JW, Simon A, Frenkel J","articleTitle":"On-demand anakinra treatment is effective in mevalonate kinase deficiency","bookWebsiteJournalTitle":"Ann Rheum Dis","date":"Dec 2011","url":"http://www.ncbi.nlm.nih.gov/pubmed/21859689","dateAccessed":"2012-02-02T00:00:00"},{"referenceId":4935,"authors":"Neven B, Valayannopoulos V, Quartier P, Blanche S, Prieur AM, Debré M, Rolland MO, Rabier D, Cuisset L, Cavazzana-Calvo M, de Lonlay P, Fischer A","articleTitle":"Allogeneic Bone Marrow Transplantation in Mevalonic Aciduria","bookWebsiteJournalTitle":"New England Journal of Medicine","date":"2007","url":"http://www.nejm.org/doi/full/10.1056/NEJMoa070715#t=articleTop","dateAccessed":"2012-02-02T00:00:00"},{"referenceId":4936,"authors":"Arkwright PD, Abinun M, Cant AJ","articleTitle":"Mevalonic Aciduria Cured by Bone Marrow Transplantation","bookWebsiteJournalTitle":"New England Journal of Medicine","date":"2007","url":"http://www.nejm.org/doi/full/10.1056/NEJMc072018","dateAccessed":"2012-02-02T00:00:00"}]},{"questionId":5944,"questionText":"Is enzyme replacement therapy available for mevalonic aciduria?","answerText":"Enzyme replacement therapy is not currently available for mevalonic aciduria.[4937] \r\n<p>More information related to this potential treatment&nbsp;is available through the following article.</p>\r\n<p class=desc>Buhaescu I, Izzedine H.&nbsp;<font color=#000000><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17467679\" target=_blank>Mevalonate pathway: a review of clinical and therapeutical implications</a>.</font><span class=jrnl title=\"Clinical biochemistry\">&nbsp;Clin Biochem</span>. 2007 Jun;40(9-10):575-84.</p>","dateModified":"2012-02-02T14:44:00","references":[{"referenceId":4937,"authors":"Buhaescu I, Izzedine H","articleTitle":"Mevalonate pathway: a review of clinical and therapeutical implications","bookWebsiteJournalTitle":"Clin Biochem","date":"2007","url":"http://www.ncbi.nlm.nih.gov/pubmed?term=17467679","dateAccessed":"2012-02-02T00:00:00"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13743,"phenoTypeName":"Cerebral cortical atrophy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10703,"phenoTypeName":"Delayed skeletal maturation","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9864,"phenoTypeName":"Dolichocephaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5603,"phenoTypeName":"Downslanted palpebral fissures","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9826,"phenoTypeName":"Large fontanelles","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9844,"phenoTypeName":"Microcephaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3605,"phenoTypeName":"Short stature","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10399,"phenoTypeName":"Triangular face","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9177,"phenoTypeName":"Blue sclerae","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5624,"phenoTypeName":"Cataract","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10438,"phenoTypeName":"Low-set, posteriorly rotated ears","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10590,"phenoTypeName":"Kyphoscoliosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11420,"phenoTypeName":"Agenesis of cerebellar vermis","percentRanges":"-"},{"phenoTypeId":7919,"phenoTypeName":"Arthralgia","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":8731,"phenoTypeName":"Cerebellar atrophy","percentRanges":"-"},{"phenoTypeId":13447,"phenoTypeName":"Cerebral atrophy","percentRanges":"-"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","percentRanges":"-"},{"phenoTypeId":8259,"phenoTypeName":"Edema","percentRanges":"-"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","percentRanges":"-"},{"phenoTypeId":10933,"phenoTypeName":"Elevated serum creatine kinase","percentRanges":"-"},{"phenoTypeId":13033,"phenoTypeName":"Elevated urine mevalonic acid","percentRanges":"-"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","percentRanges":"-"},{"phenoTypeId":10207,"phenoTypeName":"Fluctuating hepatomegaly","percentRanges":"-"},{"phenoTypeId":9561,"phenoTypeName":"Fluctuating splenomegaly","percentRanges":"-"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","percentRanges":"-"},{"phenoTypeId":11543,"phenoTypeName":"Increased circulating IgD level","percentRanges":"-"},{"phenoTypeId":13075,"phenoTypeName":"Leukocytosis","percentRanges":"-"},{"phenoTypeId":11305,"phenoTypeName":"Low-set ears","percentRanges":"-"},{"phenoTypeId":13313,"phenoTypeName":"Lymphadenopathy","percentRanges":"-"},{"phenoTypeId":12943,"phenoTypeName":"Morbilliform rash","percentRanges":"-"},{"phenoTypeId":9979,"phenoTypeName":"Normocytic hypoplastic anemia","percentRanges":"-"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","percentRanges":"-"},{"phenoTypeId":10433,"phenoTypeName":"Posteriorly rotated ears","percentRanges":"-"},{"phenoTypeId":13460,"phenoTypeName":"Progressive cerebellar ataxia","percentRanges":"-"},{"phenoTypeId":3822,"phenoTypeName":"Psychomotor retardation","percentRanges":"-"},{"phenoTypeId":15512,"phenoTypeName":"Thrombocytopenia","percentRanges":"-"},{"phenoTypeId":13400,"phenoTypeName":"Vomiting","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Mevalonic_aciduria"}